Personalized Medicine and Cancer
Infographic Dec 11, 2019 | By Laura Elizabeth Lansdowne, Science Writer, Technology Networks
The aim of personalized medicine is to a move away from the traditional “one size fits all” approach to the treatment of diseases – such as cancer. For patients where standard clinical options have been exhausted, novel personalized therapeutics may be required.
Patient-derived cancer models, such as “organoids”, can help predict an individual’s response to a drug – both efficacy and toxicity – prior to administration.
Download this infographic to:
- Explore the challenges related to personalized medicine
- Compare three types of patient-derived model
- Discover how organoids can drive the development of personalized cancer treatments
Cell culture is an invaluable tool for cancer research, used in studies to improve our understanding of fundamental cancer biology and as preclinical models to develop and test drugs. For several years, cell lines have helped uncover many intricacies of cancer pathogenesis, providing a simple, low cost and rapid way to test hypotheses.READ MORE